Relay Therapeutics (RLAY) PT Lowered to $29 at JPMorgan
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Price: $19.01 --0%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Join SI Premium – FREE
JPMorgan analyst Eric Joseph lowered the price target on Relay Therapeutics (NASDAQ: RLAY) to $29.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Downgrades Ero Copper (ERO) to Hold
- Eastern Air Logistics (601156:CH) PT Raised to RMB13.50 at Goldman Sachs
- Samsara Inc (IOT) PT Raised to $51 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
